SPONSOR
Imperial College London
Total Trials
9
Recruiting
9
Phases
Phase 2
Conditions studied: Chronic CoughSquamous Cell CarcinomaBreath TestDigestive System DiseaseDiagnose DiseaseObesityType 2 DiabetesThyroid Eye DiseaseVasculitisCOPD Exacerbation Acute
Imperial College London is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Chronic Cough, Squamous Cell Carcinoma, Breath Test, Digestive System Disease.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Imperial College London
How many clinical trials has Imperial College London sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by Imperial College London, of which 9 are actively recruiting participants. These trials cover conditions including Chronic Cough, Squamous Cell Carcinoma, Breath Test. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Imperial College London research focus on?
Imperial College London clinical trials span Chronic Cough, Squamous Cell Carcinoma, Breath Test, Digestive System Disease, Diagnose Disease, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Imperial College London clinical trial?
To participate in a Imperial College London trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Imperial College London trials with current recruitment status updated daily.
Clinical Trials by Imperial College London
NCT06286163
Recruiting
Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients
Chronic Cough
NCT04475952
Recruiting
Early Diagnosis of Upper Digestive Tract Disease
Squamous Cell Carcinoma
NCT04432025
Recruiting
Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus
Obesity
NCT05012033
Recruiting
Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
Thyroid Eye Disease
NCT07192393
Recruiting
Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).
Prematurity; Extreme
NCT05539040
Recruiting
The Role of Right Atrial Ectopy Triggering Ganglionated Plexuses in AF
Cardiac Arrhythmia
NCT06280781
Recruiting
Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance)
Prostate Cancer
NCT04319367 Phase 2
Recruiting
A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
HIV/AIDS and Infections
NCT07366619
Recruiting
Magic Angle Direction Imaging (MADI) ACL Study
Anterior Cruciate Ligament Injuries
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology